LncRNA NOC2L‐4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR‐630/YAP1 pathway
- 17 May 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (10) , 16913-16920
Abstract
Long noncoding RNA (lncRNA) is a new class of noncoding RNA playing an indispensable role in different diseases by regulating miRNA. Our previous studies have suggested that miR‐630 was decreased in patients with cervical cancer. Recently, studies have shown that lncRNA NOC2L‐4.1 was abnormally expressed in patients with cervical cancer and can target miR‐630. Therefore, we wanted to identify the integrated relationship between lncRNA NOC2L‐4.1 and miR‐630 in the pathological processes regarding cervical cancer either in vitro or in vivo. Quantitative reverse transcription‐polymerase chain reaction detection shows that compared with human normal cervical epithelial cell, the expression of lncRNA NOC2L‐4.1 was significantly increased and the expression of miR‐630 was decreased in cell lines of cervical cancer. Moreover, luciferase reporter assay showed that miR‐630 was a target of lncRNA NOC2L‐4.1. The in vitro study found that downregulation of lncRNA NOC2L‐4.1 suppressed cervical cancer cell migration (transwell assays) and proliferation (cell counting kit‐8 and cloning formation assays). miR‐630 specific inhibitor treatment reversed the inhibitory effect of lncRNA NOC2L‐4.1 on cell proliferation and migration. Further studies also found that yes‐associated protein 1 (YAP1) was the target of miR‐630. Overexpression YAP1 suppressed miR‐630 overexpression induced cell proliferation and inhibition of migration. Tumors induced by implantation of lncRNA NOC2L‐4.1‐knockdown Hela cells in nude mice showed that lncRNA NOC2L‐4.1 silencing decreased the growth of tumors in both volume and weight by regulation of miR‐630/YAP1. Taken together, our study reveals the important role of lncRNA NOC2L‐4.1/miR‐630/YAP1 regulatory network in cervical cancer, which provides new insights concerning the pathogenesis of cervical cancer.Keywords
Funding Information
- Key Scientific Research Project of Natural Science in Colleges and Universities of Anhui Province (KJ2018A0267)
This publication has 20 references indexed in Scilit:
- Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axisCell Death & Disease, 2018
- Role of Long Noncoding RNA 799 in the Metastasis of Cervical Cancer through Upregulation of TBL1XR1 ExpressionMolecular Therapy Nucleic Acids, 2018
- A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1Genome Biology, 2018
- LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathwayCell Death & Disease, 2018
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- miR-630 functions as a tumor oncogene in renal cell carcinomaArchives of Medical Science, 2016
- MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cellsCell Death & Disease, 2014
- A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in CancerCancer Cell, 2014
- Long non-coding RNAs: insights into functionsNature Reviews Genetics, 2009
- MicroRNAsCell, 2004